Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Therapy | 69 | 2023 | 1577 | 6.830 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 70 | 2023 | 2370 | 4.990 |
Why?
|
| Radiotherapy, Intensity-Modulated | 34 | 2023 | 2104 | 2.870 |
Why?
|
| Radiotherapy, Conformal | 15 | 2012 | 902 | 2.190 |
Why?
|
| Radiometry | 25 | 2023 | 980 | 2.120 |
Why?
|
| Radiotherapy Dosage | 59 | 2023 | 3842 | 1.940 |
Why?
|
| Protons | 18 | 2023 | 473 | 1.560 |
Why?
|
| Radiotherapy, High-Energy | 9 | 2014 | 295 | 1.370 |
Why?
|
| Radiation Dosage | 18 | 2013 | 1014 | 1.320 |
Why?
|
| Uncertainty | 12 | 2017 | 320 | 1.310 |
Why?
|
| Movement | 11 | 2017 | 556 | 1.270 |
Why?
|
| Quality Assurance, Health Care | 9 | 2019 | 585 | 1.210 |
Why?
|
| Algorithms | 23 | 2019 | 3890 | 1.170 |
Why?
|
| Four-Dimensional Computed Tomography | 6 | 2017 | 226 | 1.140 |
Why?
|
| Radiotherapy | 11 | 2018 | 1824 | 1.080 |
Why?
|
| Scattering, Radiation | 15 | 2016 | 316 | 1.060 |
Why?
|
| Ependymoma | 3 | 2023 | 242 | 0.950 |
Why?
|
| Phantoms, Imaging | 23 | 2023 | 1271 | 0.920 |
Why?
|
| Organs at Risk | 14 | 2023 | 514 | 0.890 |
Why?
|
| Particle Accelerators | 7 | 2010 | 352 | 0.860 |
Why?
|
| Research Report | 2 | 2013 | 144 | 0.770 |
Why?
|
| Tomography, X-Ray Computed | 25 | 2019 | 7551 | 0.750 |
Why?
|
| Respiration | 5 | 2017 | 447 | 0.720 |
Why?
|
| Precision Medicine | 4 | 2013 | 1154 | 0.660 |
Why?
|
| Reproducibility of Results | 24 | 2019 | 6009 | 0.650 |
Why?
|
| Radiotherapy, Image-Guided | 3 | 2014 | 304 | 0.650 |
Why?
|
| Equipment Failure Analysis | 7 | 2014 | 329 | 0.610 |
Why?
|
| Head and Neck Neoplasms | 15 | 2019 | 3976 | 0.600 |
Why?
|
| Monte Carlo Method | 7 | 2023 | 671 | 0.580 |
Why?
|
| Lung Neoplasms | 15 | 2017 | 11538 | 0.570 |
Why?
|
| Prostatic Neoplasms | 19 | 2014 | 5767 | 0.560 |
Why?
|
| Water | 8 | 2013 | 361 | 0.550 |
Why?
|
| Models, Statistical | 5 | 2013 | 1171 | 0.540 |
Why?
|
| Eye | 1 | 2017 | 301 | 0.540 |
Why?
|
| Radiation Oncology | 2 | 2010 | 529 | 0.520 |
Why?
|
| Artifacts | 6 | 2011 | 532 | 0.480 |
Why?
|
| Thoracic Neoplasms | 1 | 2017 | 337 | 0.470 |
Why?
|
| Film Dosimetry | 3 | 2010 | 59 | 0.460 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2019 | 202 | 0.450 |
Why?
|
| Radiotherapy Setup Errors | 4 | 2014 | 80 | 0.450 |
Why?
|
| Equipment Design | 10 | 2014 | 1204 | 0.450 |
Why?
|
| Sensitivity and Specificity | 13 | 2014 | 4971 | 0.430 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 2403 | 0.410 |
Why?
|
| Chondrosarcoma | 3 | 2014 | 216 | 0.390 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 126 | 0.390 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2015 | 421 | 0.390 |
Why?
|
| Tumor Burden | 8 | 2017 | 1987 | 0.380 |
Why?
|
| Pleural Neoplasms | 2 | 2005 | 470 | 0.380 |
Why?
|
| Gamma Rays | 1 | 2011 | 242 | 0.380 |
Why?
|
| Photons | 8 | 2018 | 507 | 0.370 |
Why?
|
| Physics | 1 | 2010 | 44 | 0.370 |
Why?
|
| Relative Biological Effectiveness | 6 | 2016 | 219 | 0.360 |
Why?
|
| Mesothelioma | 2 | 2005 | 544 | 0.360 |
Why?
|
| Models, Theoretical | 6 | 2012 | 785 | 0.350 |
Why?
|
| Oropharyngeal Neoplasms | 4 | 2016 | 1105 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2019 | 1648 | 0.350 |
Why?
|
| Humans | 91 | 2023 | 261506 | 0.340 |
Why?
|
| Quality Control | 5 | 2019 | 457 | 0.340 |
Why?
|
| Software | 5 | 2010 | 1321 | 0.310 |
Why?
|
| Breath Holding | 2 | 2017 | 44 | 0.300 |
Why?
|
| Computer Simulation | 7 | 2013 | 1529 | 0.280 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2018 | 5437 | 0.280 |
Why?
|
| Radiation Monitoring | 2 | 2006 | 49 | 0.250 |
Why?
|
| Neoplasms | 8 | 2014 | 15193 | 0.240 |
Why?
|
| Databases, Factual | 1 | 2010 | 2218 | 0.230 |
Why?
|
| Chordoma | 2 | 2014 | 163 | 0.210 |
Why?
|
| Nasal Septum | 1 | 2002 | 47 | 0.210 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 1162 | 0.210 |
Why?
|
| Organ Sparing Treatments | 4 | 2016 | 277 | 0.200 |
Why?
|
| Fiducial Markers | 2 | 2011 | 96 | 0.190 |
Why?
|
| Skull Base Neoplasms | 2 | 2014 | 314 | 0.180 |
Why?
|
| Male | 37 | 2017 | 123000 | 0.180 |
Why?
|
| Nose Neoplasms | 1 | 2002 | 229 | 0.180 |
Why?
|
| Silicon | 1 | 2000 | 48 | 0.180 |
Why?
|
| Patient Positioning | 2 | 2013 | 195 | 0.180 |
Why?
|
| Internship and Residency | 1 | 2010 | 1375 | 0.170 |
Why?
|
| Positron-Emission Tomography | 4 | 2023 | 2173 | 0.160 |
Why?
|
| Esophagus | 3 | 2017 | 553 | 0.160 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2012 | 726 | 0.160 |
Why?
|
| Radiography | 7 | 2016 | 1904 | 0.150 |
Why?
|
| Radiation Injuries | 6 | 2016 | 1411 | 0.150 |
Why?
|
| Retrospective Studies | 13 | 2017 | 37905 | 0.150 |
Why?
|
| Brain Neoplasms | 5 | 2014 | 4849 | 0.150 |
Why?
|
| Papillomaviridae | 2 | 2018 | 624 | 0.150 |
Why?
|
| Respiratory Mechanics | 2 | 2014 | 173 | 0.140 |
Why?
|
| Stomatitis | 2 | 2016 | 183 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2016 | 5319 | 0.140 |
Why?
|
| Models, Biological | 3 | 2012 | 3254 | 0.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2008 | 361 | 0.130 |
Why?
|
| Calibration | 7 | 2012 | 337 | 0.130 |
Why?
|
| Normal Distribution | 2 | 2012 | 61 | 0.130 |
Why?
|
| Simulation Training | 1 | 2017 | 149 | 0.130 |
Why?
|
| X-Rays | 2 | 2006 | 146 | 0.120 |
Why?
|
| Lung | 5 | 2017 | 3151 | 0.120 |
Why?
|
| Synchrotrons | 3 | 2022 | 35 | 0.120 |
Why?
|
| Seminoma | 1 | 2014 | 81 | 0.120 |
Why?
|
| Orbit | 1 | 2015 | 205 | 0.120 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2014 | 84 | 0.120 |
Why?
|
| Parotid Neoplasms | 1 | 2014 | 148 | 0.120 |
Why?
|
| Rectum | 5 | 2013 | 467 | 0.120 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 142 | 0.110 |
Why?
|
| Orbital Neoplasms | 1 | 2015 | 224 | 0.110 |
Why?
|
| Craniospinal Irradiation | 1 | 2014 | 128 | 0.110 |
Why?
|
| Urinary Bladder | 5 | 2013 | 575 | 0.110 |
Why?
|
| Xerostomia | 1 | 2014 | 190 | 0.110 |
Why?
|
| Tongue Neoplasms | 1 | 2014 | 246 | 0.110 |
Why?
|
| Spine | 1 | 2013 | 293 | 0.110 |
Why?
|
| Motion | 1 | 2012 | 193 | 0.100 |
Why?
|
| Consensus | 1 | 2016 | 978 | 0.100 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2014 | 323 | 0.100 |
Why?
|
| Time and Motion Studies | 1 | 2011 | 43 | 0.100 |
Why?
|
| Magnetic Field Therapy | 1 | 2011 | 6 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 980 | 0.100 |
Why?
|
| Rotation | 3 | 2013 | 112 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 502 | 0.090 |
Why?
|
| Biophysical Phenomena | 2 | 2001 | 112 | 0.090 |
Why?
|
| Radiosurgery | 1 | 2000 | 1330 | 0.090 |
Why?
|
| Mediastinal Neoplasms | 1 | 2014 | 423 | 0.090 |
Why?
|
| Electrons | 2 | 2010 | 168 | 0.090 |
Why?
|
| Biophysics | 2 | 2001 | 111 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2017 | 851 | 0.090 |
Why?
|
| Facility Design and Construction | 1 | 2009 | 11 | 0.090 |
Why?
|
| Adult | 12 | 2016 | 77950 | 0.090 |
Why?
|
| Systems Integration | 1 | 2010 | 76 | 0.090 |
Why?
|
| Aged | 12 | 2017 | 70117 | 0.090 |
Why?
|
| Metals | 2 | 2008 | 155 | 0.090 |
Why?
|
| Neutrons | 1 | 2010 | 117 | 0.090 |
Why?
|
| Spinal Neoplasms | 2 | 2012 | 631 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 5395 | 0.090 |
Why?
|
| Air | 2 | 2006 | 63 | 0.090 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2009 | 77 | 0.080 |
Why?
|
| Abdominal Cavity | 1 | 2008 | 20 | 0.080 |
Why?
|
| Hodgkin Disease | 1 | 2017 | 1429 | 0.080 |
Why?
|
| Time Factors | 5 | 2015 | 12926 | 0.080 |
Why?
|
| Prostate | 3 | 2013 | 1088 | 0.080 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 133 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2014 | 2803 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2012 | 925 | 0.070 |
Why?
|
| Gold | 1 | 2009 | 270 | 0.070 |
Why?
|
| Ions | 1 | 2006 | 53 | 0.070 |
Why?
|
| Filtration | 1 | 2006 | 92 | 0.070 |
Why?
|
| Spinal Cord | 3 | 2015 | 690 | 0.070 |
Why?
|
| Middle Aged | 11 | 2017 | 86204 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 672 | 0.070 |
Why?
|
| Female | 13 | 2017 | 141928 | 0.060 |
Why?
|
| Chemoradiotherapy | 1 | 2014 | 1946 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 14889 | 0.060 |
Why?
|
| Body Burden | 1 | 2004 | 65 | 0.060 |
Why?
|
| Texas | 3 | 2011 | 6311 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2006 | 295 | 0.060 |
Why?
|
| Brain | 3 | 2014 | 4113 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2006 | 402 | 0.060 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 1202 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2578 | 0.060 |
Why?
|
| Polymethyl Methacrylate | 1 | 2023 | 41 | 0.060 |
Why?
|
| Glioma | 1 | 2014 | 1963 | 0.060 |
Why?
|
| Child | 5 | 2015 | 29154 | 0.060 |
Why?
|
| United States | 2 | 2013 | 15433 | 0.050 |
Why?
|
| Radiation Tolerance | 2 | 2016 | 629 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2006 | 1301 | 0.050 |
Why?
|
| X-Ray Film | 1 | 2000 | 31 | 0.050 |
Why?
|
| DNA Repair | 2 | 2019 | 1872 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2006 | 1226 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 10035 | 0.050 |
Why?
|
| Pneumonectomy | 1 | 2005 | 831 | 0.040 |
Why?
|
| Quality of Life | 1 | 2013 | 4532 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2016 | 32848 | 0.040 |
Why?
|
| Femur Head | 2 | 2010 | 41 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 7789 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2000 | 286 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2000 | 875 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2014 | 2292 | 0.040 |
Why?
|
| Seminal Vesicles | 2 | 2013 | 152 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 3168 | 0.040 |
Why?
|
| Necrosis | 1 | 2018 | 580 | 0.040 |
Why?
|
| Radiation Protection | 1 | 1998 | 205 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2018 | 382 | 0.040 |
Why?
|
| Mitosis | 1 | 2018 | 615 | 0.030 |
Why?
|
| Heart | 2 | 2014 | 1223 | 0.030 |
Why?
|
| Models, Structural | 1 | 1995 | 103 | 0.030 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 13658 | 0.030 |
Why?
|
| Mathematics | 1 | 1995 | 136 | 0.030 |
Why?
|
| Computer Graphics | 1 | 2015 | 82 | 0.030 |
Why?
|
| Ethmoid Bone | 1 | 2014 | 14 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 1099 | 0.030 |
Why?
|
| Sexuality | 1 | 2013 | 38 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 14551 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8865 | 0.030 |
Why?
|
| Cranial Irradiation | 1 | 2015 | 315 | 0.030 |
Why?
|
| Urination Disorders | 1 | 2013 | 61 | 0.030 |
Why?
|
| Eyelid Neoplasms | 1 | 2015 | 191 | 0.030 |
Why?
|
| Cochlea | 1 | 2013 | 102 | 0.030 |
Why?
|
| Lacrimal Apparatus | 1 | 2015 | 181 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 29902 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2015 | 16273 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 2013 | 155 | 0.030 |
Why?
|
| Induction Chemotherapy | 1 | 2016 | 669 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 1391 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 1380 | 0.030 |
Why?
|
| Brain Stem | 1 | 2013 | 175 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2014 | 355 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 10001 | 0.030 |
Why?
|
| Erythema | 1 | 2012 | 52 | 0.030 |
Why?
|
| Bone and Bones | 1 | 1995 | 619 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 2016 | 447 | 0.030 |
Why?
|
| Thiosemicarbazones | 1 | 1991 | 23 | 0.020 |
Why?
|
| Ceramics | 1 | 2010 | 11 | 0.020 |
Why?
|
| Stainless Steel | 1 | 2010 | 26 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2015 | 873 | 0.020 |
Why?
|
| Elementary Particle Interactions | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cornea | 1 | 2015 | 638 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 1085 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 3045 | 0.020 |
Why?
|
| Carbon | 1 | 2010 | 149 | 0.020 |
Why?
|
| Technology, Radiologic | 1 | 2010 | 80 | 0.020 |
Why?
|
| Copper | 1 | 1991 | 165 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 2231 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1991 | 191 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2016 | 12873 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 2009 | 49 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2015 | 899 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2009 | 64 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 2013 | 341 | 0.020 |
Why?
|
| Head | 1 | 2011 | 249 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 4892 | 0.020 |
Why?
|
| Pelvis | 1 | 2011 | 362 | 0.020 |
Why?
|
| Adolescent | 3 | 2015 | 31252 | 0.020 |
Why?
|
| Intestines | 1 | 2013 | 686 | 0.020 |
Why?
|
| Software Validation | 1 | 2008 | 32 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1954 | 0.020 |
Why?
|
| Aluminum | 1 | 2008 | 19 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 1972 | 0.020 |
Why?
|
| Titanium | 1 | 2008 | 61 | 0.020 |
Why?
|
| Registries | 1 | 2016 | 2170 | 0.020 |
Why?
|
| Kidney | 2 | 2014 | 2146 | 0.020 |
Why?
|
| Dental Amalgam | 1 | 2006 | 8 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1991 | 750 | 0.020 |
Why?
|
| Mouth Protectors | 1 | 2006 | 6 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2006 | 50 | 0.020 |
Why?
|
| Masks | 1 | 2006 | 57 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 2307 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 3719 | 0.020 |
Why?
|
| Fatigue | 1 | 2012 | 1239 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 5377 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 7591 | 0.020 |
Why?
|
| Liver | 1 | 2011 | 2961 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 11965 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 6100 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12221 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 5047 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 13310 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 21445 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 14289 | 0.010 |
Why?
|
| Antipyrine | 1 | 1991 | 8 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1991 | 114 | 0.010 |
Why?
|
| Microspheres | 1 | 1991 | 210 | 0.010 |
Why?
|
| Cricetinae | 1 | 1991 | 706 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1991 | 310 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1991 | 1519 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1991 | 665 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1991 | 1390 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 59536 | 0.000 |
Why?
|